BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,407 | +9.7% | 26,545 | +45.7% | 0.01% | +16.7% |
| Q2 2023 | $581,892 | +19.1% | 18,224 | +14.2% | 0.01% | +20.0% |
| Q1 2023 | $488,695 | +3.8% | 15,960 | +32.6% | 0.01% | -16.7% |
| Q4 2022 | $470,806 | -20.2% | 12,038 | -2.8% | 0.01% | -25.0% |
| Q3 2022 | $590,000 | +26.1% | 12,380 | +2.4% | 0.01% | +33.3% |
| Q2 2022 | $468,000 | -29.7% | 12,085 | +3.9% | 0.01% | -14.3% |
| Q1 2022 | $666,000 | -18.9% | 11,631 | +12.9% | 0.01% | -22.2% |
| Q4 2021 | $821,000 | -8.4% | 10,298 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $896,000 | – | 10,298 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |